US Stocks
/
Context Therapeutics Inc. Share Price

Context Therapeutics Inc. Share Price

NASDAQ: CNTX | Micro Cap
$0.53
+$0.06 (12.36%) Last updated on 15 Aug, 2026 | 00:15 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Context Therapeutics Inc. Stock Performance

Open
$0.50
Prev. Close
$0.47
Circuit Range
N/A
Day Range
$0.49 - $0.53
Year Range
$0.43 - $3.60
Volume
17,289
Average Traded
$0.51

Context Therapeutics Inc. Share Price Today

As of 15 August 2026, Context Therapeutics Inc.'s share price is $0.53. The stock opened at $0.50, compared to its previous close of $0.47. During today's trading session, Context Therapeutics Inc.'s share price traded between $0.49 and $0.53, with an average price of $0.51. Over the past 52 weeks, the stock has recorded a high of $3.60 and a low of $0.43. In terms of performance, Context Therapeutics Inc.'s share price has declined by 76.66% over the last six months and is down 38.03% on a year-on-year basis.

Context Therapeutics Inc. Share Price Chart

$0.49$0.53
L
Show Current Price
H

Context Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$50.20M
PE Ratio (TTM)
-1.39
Dividend Yield
N/A
EPS (TTM)
$-0.38
Revenue (TTM)
N/A
Return On Equity (TTM)
-59.73%
Profit Margin
N/A
Debt to Equity
0.13
Quarterly Earnings Growth YoY
44.48%

Context Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$3.67M-$2.25M-$17.46M-$4.58M-$8.83M-$9.69M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A38.53%-674.44%73.78%-92.86%-9.81%

Context Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$10.46M-$14.84M-$23.96M-$26.73M-$36.12M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-41.88%-61.53%-11.52%-35.17%

About Context Therapeutics Inc.

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. The company was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.

Context Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$0.61
$0.53
-11.73%
Jul 2026
$0.57
$0.60
+8.55%
Jun 2026
$2.83
$0.55
-80.77%
May 2026
$2.32
$2.86
+21.19%
Apr 2026
$2.71
$2.36
-10.27%
Mar 2026
$2.14
$2.63
+16.37%
Feb 2026
$2.68
$2.26
-13.90%
Jan 2026
$1.47
$2.63
+79.79%
Dec 2025
$1.09
$1.46
+30.36%
Nov 2025
$1.07
$1.12
+3.23%
Oct 2025
$0.96
$1.08
+14.21%
Sep 2025
$0.85
$0.95
+11.63%

CNTX Share Price FAQs

What is Context Therapeutics Inc. share price today?

chevron-up
Context Therapeutics Inc. share price today is $0.53 as on August 15, 2026 at 12:15 am IST.

What is the 52 week high and 52 week low of Context Therapeutics Inc. stock?

chevron-up
The 52 week high of Context Therapeutics Inc. stock is $3.60, while the 52 week low is $0.43 as of 15 Aug '26.

What is CNTX's market capitalisation today?

chevron-up
CNTX market capitalisation is $50.20M as of August 15, 2026, at 12:19 am IST.

What is CNTX's net income for the last quarter?

chevron-up
CNTX's net income for the last quarter is -0.01B USD.

What is the 5 year returns of CNTX?

chevron-up
The 5 year returns of CNTX is -90.91% as on 15 Aug '26.

What is the high & low stock price of CNTX today?

chevron-up
CNTX stock price hit a high of $0.53 and low of $0.49 as of 15 Aug '26.

Can I buy CNTX shares in India?

chevron-up
Yes. You can buy CNTX in India by opening an international trading account.